超重/肥胖患者并发冠心病的风险预警模型的中西医研究进展
Research Progress of Integrated Traditional Chinese and Western Medicine in Risk Early Warning Models for Coronary Artery Disease Complicated with Overweight/Obesity
DOI: 10.12677/tcm.2026.151028, PDF,    科研立项经费支持
作者: 彭晓婉, 陈 秋:成都中医药大学附属医院内分泌科,四川 成都
关键词: 超重肥胖冠心病风险预警中西医结合Overweight Obesity Coronary Heart Disease Risk Prediction Integrated Traditional Chinese Medicine and Western Medicine
摘要: 随着全球超重/肥胖流行率攀升,其引发冠心病的风险及致死负担日益严峻,风险预警模型成为精准防控的关键工具。本文系统梳理相关研究进展:西医模型从传统回归模型演进至机器学习模型,通过整合临床指标、生物标志物及多组学数据,预测精度持续提升,但存在“黑箱”局限与人群适配性问题;中医模型以证素评分和中西医结合量表为核心,紧扣“痰浊”“血瘀”等核心证素,体现整体辨证特色,却面临量化标准不统一的挑战;中西医结合模型通过“指标叠加”与“机制融合”两种模式,实现微观指标与宏观辨证互补,展现最优预测效能。现有研究存在样本代表性不足、验证体系不完善等问题,未来需依托多中心大样本队列,推动指标创新、技术突破与临床转化,构建精准化、可解释、实用性强的新一代预警模型。
Abstract: With the global rise in the prevalence of overweight/obesity, the risk of coronary heart disease and the associated mortality burden it poses have become increasingly severe, making risk prediction models a key tool for precision prevention and control. This article systematically reviews the relevant research progress: Western medicine models have evolved from traditional regression models to machine learning models, with continuously improved prediction accuracy through the integration of clinical indicators, biomarkers, and multi-omics data. However, they face limitations such as the “black box” problem and population adaptability issues. Traditional Chinese medicine (TCM) models, centered on syndrome element scoring and integrated TCM-Western medicine scales, focus on core syndrome elements like phlegm turbidity and blood stasis, reflecting the characteristic of holistic syndrome differentiation, but encounter challenges such as inconsistent quantification standards. Integrated TCM-Western medicine models, through two modes—“index superposition” and “mechanism integration”—achieve the complementarity of microcosmic indicators and macrocosmic syndrome differentiation, demonstrating the optimal predictive performance. Existing studies suffer from insufficient sample representativeness and imperfect validation systems. Future research should rely on multi-center, large-sample prospective cohorts to promote indicator innovation, technological breakthroughs, and clinical translation, thereby constructing a new generation of prediction models that are precise, interpretable, and highly practical.
文章引用:彭晓婉, 陈秋. 超重/肥胖患者并发冠心病的风险预警模型的中西医研究进展[J]. 中医学, 2026, 15(1): 200-206. https://doi.org/10.12677/tcm.2026.151028

参考文献

[1] World Obesity Federation (2025) World Obesity Atlas 2025: Overweight, Obesity and Non-Communicable Diseases.
[2] Global Burden of Disease 2021 Cardiovascular Disease Collaborators (2023) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2021. JAMA Cardiology, 8, 1-22.
[3] American Heart Association (2021) Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation, 144, e98-e125.
[4] Sun, Y., et al. (2023) Adrenomedullin Mediates Obesity-Induced Endothelial Insulin Resistance. Science, 380, 294-298.
[5] Mancia, G., et al. (2023) 2023 ESC/ESH Guidelines for the Management of Arterial Hypertension. European Heart Journal, 44, 3199-3266.
[6] Lemieux, I., et al. (2020) Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Burden. Nature Reviews Endocrinology, 16, 407-425.
[7] Di Angelantonio, E., et al. (2010) Body-Mass Index and Risk of Coronary Heart Disease: A Collaborative Analysis of 58 Prospective Studies. The Lancet, 376, 1640-1649.
[8] Montezano, A.C., et al. (2021) Leptin and Cardiovascular Disease. Physiological Reviews, 101, 1465-1513.
[9] Li, Y., et al. (2019) Cardiac Troponin Elevation in Obese Patients without Acute Coronary Syndrome. JAMA Cardiology, 4, 1001-1008.
[10] Sattar, N., et al. (2019) Adipose Tissue as an Endocrine Organ. Clinical Endocrinology (Oxford), 90, 337-349.
[11] 王春烨, 黄成怡, 姚嘉敏, 等. 针刺联合脐疗贴治疗痰浊血瘀型肥胖合并高脂血症疗效观察[J]. 上海针灸杂志, 2023, 42(5): 445-452.
[12] 陈硕, 范平. 探究痰浊中阻型心绞痛患者胸痛程度与餐后血脂的关系[J]. 光明中医, 2023, 38(8): 1442-1444, 1495.
[13] Yang, S., Han, Y., Yu, C., Guo, Y., Pang, Y., Sun, D., et al. (2022) Development of a Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank. Neurology, 98, e2307-e2317. [Google Scholar] [CrossRef] [PubMed]
[14] 张林, 王燕, 李鑫, 等. 中老年肥胖人群2型糖尿病风险预测模型的建立与验证: 一项社区队列研究[J]. 中华内分泌代谢杂志, 2023, 39(8): 712-717.
[15] 李乃适, 朱惠娟, 潘慧等. 中老年肥胖人群冠心病风险预测模型的建立及验证: 一项社区队列研究[J]. 中华内分泌代谢杂志, 2022, 38(5): 401-407.
[16] 王卫庆, 李红, 金晓龙, 等. 代谢组学标志物联合机器学习在超重人群冠心病风险预测中的应用[J]. 中华心血管病杂志, 2021, 49(8): 789-796.
[17] Rafael, J., Sarah, L., David, M., et al. (2023) Explainable Machine Learning with XGBoost and SHAP for Coronary Heart Disease Risk Stratification in Obese Populations. Circulation: Cardiovascular Quality and Outcomes, 16, e009876.
[18] 吕筠, 李立明, 郭彧, 等. 中心型肥胖与缺血性心脏病发病风险的前瞻性队列研究[J]. 中华流行病学杂志, 2019, 40(3): 273-279.
[19] 顾东风, 吴锡桂, 段秀芳, 等. 西方冠心病风险预测模型在我国人群的适用性评价[J]. 中华心血管病杂志, 2020, 48(7): 553-559.
[20] 姚魁武, 刘咏梅, 陈光, 等. 基于中医证素的肥胖并发冠心病风险评分模型构建及验证[J]. 北京中医药大学学报, 2023, 46(4): 789-796.
[21] 方祝元, 周仲瑛, 薛博瑜, 等. 基于分级证素的肥胖合并冠心病中医风险预测模型构建[J]. 南京中医药大学学报, 2024, 40(2): 256-262.
[22] 冼绍祥, 吴伟, 杨小波, 等. 中医舌脉象量化结合Logistic回归构建肥胖人群冠心病预测模型[J]. 中医杂志, 2023, 64(11): 1089-1095.
[23] 王阶, 朱明军, 李军, 等. 肥胖人群冠心病风险中医预警量表的建立与评价[J]. 中华中医药杂志, 2013, 28(10): 2939-2943.
[24] 朱明军, 王阶, 李越, 等. 基于中西医指标的肥胖人群冠心病风险预测模型建立与评价[J]. 中国中西医结合杂志, 2015, 35(5): 534-539.
[25] 仝小林, 倪青. 痰浊的微观化研究进展[J]. 中国中医基础医学杂志, 2004, 10(6): 21-23.
[26] 刘杏, 吴焕林, 邹旭, 等. 基于数据挖掘的冠心病痰瘀互结证诊断模型研究[J]. 中国中西医结合杂志, 2018, 38(7): 795-799.
[27] Wang, Y., Zhang, D., Liu, G., et al. (2021) A New Method for the Automatic Classification of Traditional Chinese Medicine Tongue Images Based on a Deep Convolutional Neural Network. Journal of Ethnopharmacology, 268, Article ID: 113635.
[28] 王阶, 何庆勇. 冠心病中医辨证论治体系及疗效评价研究述评[J]. 世界科学技术-中医药现代化, 2010, 12(5): 706-710.